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Background: A number of dietary quality indices (DQIs) have been developed to assess the quality of dietary
intake. Analysis of the intake of individual nutrients does not reflect the complexity of dietary behaviours and their
association with health and disease. The aim of this study was to determine the dietary quality of individuals with
type 2 diabetes mellitus (T2DM) using a variety of validated DQIs.
Methods: In this cross-sectional analysis of 111 Caucasian adults, 65 cases with T2DM were recruited from the
Diabetes Day Care Services of St. Columcille’s and St. Vincent’s Hospitals, Dublin, Ireland. Forty-six controls did not
have T2DM and were recruited from the general population. Data from 3-day estimated diet diaries were used to
calculate 4 DQIs.
Results: Participants with T2DM had a significantly lower score for consumption of a Mediterranean dietary pattern
compared to the control group, measured using the Mediterranean Diet Score (Range 0–9) and the Alternate
Mediterranean Diet Score (Range 0–9) (mean ± SD) (3.4 ± 1.3 vs 4.8 ± 1.8, P < 0.001 and 3.3 ± 1.5 vs 4.2 ± 1.8, P = 0.02
respectively). Participants with T2DM also had lower dietary quality than the control population as assessed by the
Healthy Diet Indicator (Range 0–9) (T2DM; 2.6 ± 2.3, control; 3.3 ± 1.1, P = 0.001). No differences between the two
groups were found when dietary quality was assessed using the Alternate Healthy Eating Index. Micronutrient
intake was assessed using the Micronutrient Adequacy Score (Range 0–8) and participants with T2DM had a
significantly lower score than the control group (T2DM; 1.6 ± 1.4, control; 2.3 ± 1.4, P = 0.009). When individual
nutrient intakes were assessed, no significant differences were observed in macronutrient intake.
Conclusion: Overall, these findings demonstrate that T2DM was associated with a lower score when dietary quality
was assessed using a number of validated indices.
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Dietary intake plays a role in both the aetiology and
management of type 2 diabetes mellitus (T2DM), and is
a key modifiable risk factor [1]. Dietary intake, cha-
racterised by a high intake of energy and nutrients such
as fat and sugar accompanied by a low intake of fibre,* Correspondence: fiona.lithander@anu.edu.au
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reproduction in any medium, provided the orhas been shown to increase the risk of T2DM [2]. Many
national and international associations have produced
evidence-based dietary recommendations, including the
European Association for the Study of Diabetes, the
American Diabetes Association (ADA) and the Canadian
Diabetes Association (CDA), in order to help individuals
with T2DM to achieve a dietary intake that is not only
nutritionally adequate but can also help to optimise their
metabolic control. However, research has shown that
individuals with T2DM fail to achieve such nutrient re-
commendations [3-5].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to model dietary intake as opposed to nutrient specific
based approaches may offer greater health benefits, as
dietary patterns are suggested to offer a broader repre-
sentation of dietary intake and have been shown to me-
diate effects on health and disease risk [6,7]. Dietary
patterns take into account the synergistic effects of
whole foods and may prove more beneficial in terms of
assessing the quality of dietary intake [8]. For instance,
the synergistic effects of the food groups within a
Mediterranean dietary pattern were supported by ana-
lyses by Trichopoulou and colleagues, who found that
dietary pattern as a whole was inversely associated
with mortality [9].
A number of validated dietary quality indices (DQIs)
have been developed to assess the quality of dietary in-
take by using dietary pattern analyses. Such validated
DQIs include the Alternate Healthy Eating Index [10],
the Mediterranean Diet Score [9,11], the Alternate
Mediterranean Diet Score [12] and the Healthy Diet In-
dicator [13]. There is limited data available on the use of
such DQIs in populations with T2DM.
The aim of this cross-sectional study was to measure
the dietary intake of a sample of adults with T2DM and
to assess the overall quality of dietary intake using a se-
lection of validated dietary quality indices.
Methods
Participants
Participants with T2DM were recruited from the Dia-
betes Day Care Services of St. Columcille’s Hospital and
St. Vincent’s Hospital, Dublin, Ireland. Participants were
originally referred to this service by their general practi-
tioner and the cohort consisted of a mixture of both
new and returning patients. All participants with T2DM
were required to see a dietitian as part of the service al-
though it is unknown how many did. A control group,
of similar age and physical activity level was recruited
from the same catchment area as the case subjects
through distribution of advertisements to local busi-
nesses. All participants provided informed written con-
sent before participation. The study was conducted in
accordance with the principles of the Declaration of
Helsinki and was approved by the Trinity College Dublin
Faculty of Health Sciences Research Ethics Committee.
Participants with T2DM were classified as suitable for
inclusion if they were between 30 and 75 years of age,
had a date of diagnosis of T2DM within the previous
10 years and had a glycosylated hemoglobin (HbA1c)
level of <10%. Participants with T2DM were excluded if
either persistent proteinuria (urinary protein >2 mg/dL)
or excess urinary creatinine (>2 mg/dL) were detected.
Diagnoses of peripheral artery disease or coronary heart
disease were also grounds for exclusion. Controlledhypertensive participants were admitted to the study.
Non-diabetic, healthy control participants were considered
eligible for inclusion if free from any cardiovascular
disease or any other serious co-morbidity assessed by
medical questionnaire. Control participants received a
full medical examination performed by a qualified
medical practitioner prior to participation. All parti-
cipants were classified as sedentary, defined as per-
formance of less than 1 hour of moderate intensity
physical activity per week during the previous six
months. This measure was confirmed using the Low
Level Physical Activity Recall (LOPAR) questionnaire [14]
and the wearing of an RT3 accelerometer (Stayhealthy
Inc, Monrovia, California) for 5 consecutive days. Data
were also obtained on current medications used by all
participants.
Biochemical analyses
Blood samples were collected from participants follo-
wing a 12 hour overnight fast. Samples were analysed
for plasma glucose, insulin, HbA1c, total cholesterol,
high density lipoprotein cholesterol, low density lipopro-
tein cholesterol and triacylglycerides using standardised
methods. Serum insulin was not measured in the control
population due to cost limitations. All biochemical ana-
lyses were conducted at the haematological laboratory of
St. Columcille’s Hospital, Dublin, Ireland.
Assessment of dietary intake
Dietary intake was assessed using an estimated 3 day
diet diary (Medical Research Council, Human Nutrition
Research Food Diary, Cambridge, UK). Participants were
asked to record all food and beverages consumed over 3
consecutive days comprising 2 weekdays and 1 weekend
day and received verbal and written instructions on how
to complete the diary. For each food or beverage item,
participants were asked to provide details of brand
names, cooking methods used, nutritional additives used
during cooking, portion size consumed and details on
any leftovers. Participants were instructed to record por-
tion sizes as household measures, such as cups and ta-
blespoons, weights given by manufacturers on packaging
or as measures of small, medium or large portion sizes
with the assistance of a food atlas provided within the
food diary. The food atlas provided a pictorial represen-
tation of these portion sizes for 15 commonly consumed
foods. Participants were also instructed to answer a sup-
plemental dietary questionnaire contained within the
food diary which consisted of 12 questions used to
acquire information on types and brands of milk, but-
ters, spreads, oils and breads used, whether the fat and
skin of meat is usually consumed and food preparation
techniques used. Details of recipes used were also
sought, including a list of ingredients. Participants were
Murray et al. Nutrition Journal 2013, 12:110 Page 3 of 11
http://www.nutritionj.com/content/12/1/110encouraged to keep the food diary as they went about
their day and to refrain from recording retrospectively
by memory. Participants were instructed to maintain
usual eating habits throughout the assessment period.
Data on the use of nutritional supplements were also
collected and if consuming nutritional supplements, par-
ticipants were asked to provide the brand name, the
name of the nutritional supplement in full and the dos-
age of supplement taken.
Reported dietary intake was assessed for validity
through application of the Goldberg equation to deter-
mine levels of mis-reporting [15]. Under-reporters were
defined as those with an energy intake to basal meta-
bolic rate (EIrep:BMRest) ratio of < 1.1.
Nutrient analyses
Nutrient and food group analyses were conducted using
WISP (Weighed Intake Software Package) version 3.0
(Tinuviel Software) nutrient analysis software program-
me incorporating the use of McCance and Widdowson
Food Composition Tables 5th and 6th editions with
supplements. Whilst WISP contains 17 standard food
groups, the current analyses necessitated the creation of
new food group variables, including wholegrains, le-
gumes, nuts, seeds, soy, red meat, white meat and pro-
cessed meat, to enable application of the chosen DQIs.
This was carried out within the WISP software pro-
gramme by allocation of the appropriate food code to
the newly defined food groups. In addition, a Micronu-
trient Adequacy Score [16] ranging from 0–8 was calcu-
lated for eight micronutrients discussed in the ADA and
CDA evidence based nutritional guidelines for diabetes
management (vitamin C, vitamin D, vitamin E, folate,
potassium, magnesium, sodium and zinc). Each micro-
nutrient was assigned a score of 1 if the recommended
daily allowance (RDA) [17] was met and a score of 0 if
the RDA was not met. For sodium, an additional rule
was applied wherein a score of 0 was given if intake
exceeded the upper tolerable limit [18].
Assessment of dietary quality
Dietary quality was assessed using four validated DQIs.
DQIs use the data from the quantitative nutritional ana-
lysis of dietary intake in order to apply a resultant quali-
tative score. This score is then used to predict the health
outcomes that are related to the dietary pattern con-
sumed [19].
The alternate healthy eating index
This DQI is an adaptation by McCullough and col-
leagues (2002) of the original Healthy Eating Index. The
9 components are scored on a range of 0–10. The score
for each component is proportional to the extent which
the dietary guideline is met [10].The healthy diet indicator
The Healthy Diet Indicator was developed based on the
World Health Organisation (WHO) guidelines for diet
and nutrition in the prevention of chronic disease. These
guidelines were subsequently updated in 2003, however
nutritional recommendations remain unchanged. This
index applies a dichotomous scoring method, with a
total score range of 0–9. A score of +1 is given to those
who meet the recommendation for a given dietary com-
ponent and a score of 0 is given to those that do not
meet the recommendation [13].
The mediterranean diet score
Developed by Trichopoulou et al. (1995; 2003), this diet
quality assessment tool is based on the traditional diet-
ary pattern of the Mediterranean region. The index has
a total score range of 0–9. The sex-specific median in-
take is calculated for each dietary constituent and is used
as a cut-off value to aid application of scores. Consump-
tion of greater than the median amount is awarded a
score of +1, with the exception for meat and dairy,
where consumption of greater than the median amount
is awarded a score of 0 [9,11].
The alternate mediterranean diet score
Fung and colleagues (2005) developed this adaptation of
the traditional Mediterranean Diet Score. Whilst similar
to the original Mediterranean Diet Score, modifications
were made to the original Mediterranean Diet Score
based on dietary patterns and behaviours that were re-
peatedly found to be associated with reduced chronic
disease risk [12].
Anthropometry
All anthropometric measures were carried out with
participants wearing light clothing and with shoes re-
moved. Body mass was determined on a set of platform
beam scales (AVERY, United Kingdom) measured to
the nearest 0.1 kg. Height was measured to the nea-
rest 0.5 cm, using a SECA™ Stadiometer (SECA Ltd.,
Germany). Determination of height was made whereby
the participant stood with their back to the stadiometer
while looking straight ahead. Height was recorded after
subjects fully inhaled. Participant waist circumference
(WC) was measured from the level of the umbilicus,
with the hip measurement collected in line with the
greater trochanter. Both measurements were determined
using a tape measure, and measured to the nearest
1 mm. Waist:hip ratio (WHR) was then calculated from
these measures.
Statistical analyses
Values are expressed as means and standard deviation.
Continuous variables were assessed for normality of
Table 1 Mean (SD) subject characteristics of the T2DM
and control participants
T2DM Controls P value
Mean SD N Mean SD N
Age (y) 56 7.7 65 55 9.5 46 0.459
Anthropometry
Height (m) 1.7 0.1 65 1.7 0.1 46 0.564
Weight (kg) 92.1 14.1 65 78.3 16.2 46 <0.001
BMI 1 32.5 5.3 65 27.6 4.1 46 <0.001
WC (cm) 107.4 12.2 54 101.2 8.4 17 0.021
WHR 3 0.95 0.2 64 0.93 0.1 45 0.001
% Adiposity3 32.6 5.4 65 29.3 4.1 46 0.003
BMI category a
18.5-24.9 b 1 - - 14 - - -
25.0-29.9 b 26 - - 17 - - -
30.0-34.9 b 20 - - 13 - - -
35.0-39.9 b 12 - - 2 - - -
>40 b 6 - - 0 - - -
Biochemical profile
FPG (mmol/L)2 7.8 1.8 61 4.6 0.6 42 <0.001
Insulin (mU/L) 13.5 8.5 51 - - - -
HbA1c (%)2 6.8 0.9 61 5.5 0.4 33 <0.001
TC (mmol/L)1 4.4 0.9 60 5.2 1.2 43 <0.001
HDL-C (mmol/L) 1.3 0.2 52 1.6 0.5 43 0.002
LDL-C (mmol/L) 2.7 0.8 52 3.5 1.0 43 <0.001
TAG (mmol/L)1 1.8 0.7 60 1.3 0.6 42 <0.001
T2DM type 2 diabetes mellitus, SD standard deviation, N subject numbers,
BMI body mass index, WC waist circumference, WHR waist-hip ratio, FPG
fasting plasma glucose, HbA1c glycosylated haemoglobin, TC total cholesterol,
HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein
cholesterol, TAG triacylglycerides.
* a World Health Organisation classification (20); b Expressed as frequency.
1Square root transformation; 2 Log transformation; 3 Non-parametric 2-tailed t-
test analysis.
All other p-values obtained by independent 2-tailed t-test analyses between
T2DM group and control group.
Subject numbers may vary due to missing data.
Statistically significant (P < 0.05).
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Wilk and Kolmogorov-Smirnov values and through in-
spection of Q-Q plots. Continuous variables that were
skewed were log, square root and inverse transformed as
appropriate before statistical analyses were performed.
Independent sample t-tests were used to test for diffe-
rences between group means of the T2DM group and
controls. Mann Whitney-U tests were used to test for
differences between group means of non-normally dis-
tributed variables. Partial correlation co-efficients (r)
were used to examine the relationships between bio-
chemical profile, nutrient intake data, food group intake
data and dietary quality scores. All correlation analyses
were controlled for potential confounding variables, in-
cluding age, body mass index (BMI), energy intake and
medication use. Participants with T2DM who were pre-
scribed oral hypoglycaemic agents (OHAs) were ex-
cluded from such correlation analyses for glycaemic
control. Results were considered statistically significant
with values P < 0.05.
Results
Data from a total of 111 Caucasian participants were
collected for this cross-sectional study. Sixty-five partici-
pants had T2DM, 39 males and 26 females. Forty-six
participants were in the control group, 16 males and 30
females. There was no significant difference between the
T2DM group and the control group with regard to age
or activity level due to strict study inclusion criteria.
Subject characteristics
Subject characteristics are presented in Table 1. Thirty-
nine percent of the study population (n = 43) were de-
fined as overweight (BMI; 27.8 ± 1.2) (males = 28.0 ± 1.1,
females = 27.6 ± 1.3) and a further 48% as obese (n = 53),
(BMI; 34.8 ± 2.9) (males = 32.1 ± 2.5, females = 35.8 ± 5.1)
[20]. The T2DM group had a significantly greater BMI
than the control group (males = 28.5 ± 3.4, females =
27.1 ± 6.6, P < 0.001). Forty percent of participants with
T2DM (n = 26) were overweight (BMI; 28.1 ± 1.1)
(males = 28.2 ± 1.0, females = 28.0 ± 1.3) and a further
58% were obese (n = 38) (BMI; 35.7 ± 4.7) (males =
33.2 ± 2.6, females = 38.7 ± 4.9). This was greater than the
control population where 37% were overweight (n = 17)
(BMI 27.7 ± 1.2) (males = 27.9 ± 1.2, females = 27.3 ± 1.5)
and 33% were obese (n = 15) (BMI; 33.9 ± 1.2) (males =
31.0 ± 1.3, females = 33.0 ± 2.5). There was also a signifi-
cant difference in WC (P = 0.021) and WHR (P = 0.001)
between the T2DM group (WC; males = 105.5 ± 9.0 cm,
females = 111.5 ± 16.8 cm) (WHR; males = 0.9 ± 0.2, fe-
males = 1.0 ± 0.1) and the control group (WC; males =
102.4 ± 6.7 cm, females = 80.5 ± 0 cm) (WHR; males =
1.0 ± 0, females = 0.9 ± 0.1), with the T2DM group having
the greatest measure within all parameters. The T2DMgroup had higher fasting plasma glucose, HbA1c and
triacylglyceride levels, and a lower high density lipoprotein
cholesterol level (all, P < 0.05). Sixty-two participants
(n = 57 with T2DM and n = 5 control participants)
were prescribed medications. Of the 57 participants
with T2DM, 49 were taking OHAs, 45 were taking
anti-hypertensive medications, 27 were prescribed sta-
tin medications. Of the control participants, 2 were
prescribed anti-hypertensive medications and 5 were
prescribed statin medication. The control participants
were a representative sample of the national popula-
tion in terms of BMI and habitual nutrient intake by
comparison with the recently published national data
[21].
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Table 2 presents mean daily nutrient intake of the sam-
ple population. Application of Goldberg cut-off values
for EIrep:BMRest found that 74 participants under-repor-
ted energy intake. The level of under-reporting of energy
intake was found to be equally distributed between bothTable 2 Mean (SD) daily nutrient intake of T2DM and control
T2DM
Mean SD
Energy (MJ/day) 7.7 2.1
Protein (g) 81.3 22.8
% en protein1 18.0 3.2
CHO (g)1 206.9 67.7
% en CHO 42.8 7.7
Total sugars (g)1 73.1 31.0
% en total sugars2 15.2 5.0
NMES (g)2 29.1 23.4
Fibre (AOAC) (g)1 17.9 5.5
Total fat (g) 72.5 26.7
% en total fat 35.2 8.0
SFA (g) 25.6 10.4
% en SFA 12.5 3.9
MUFA (g) 23.5 9.2
% en MUFA 11.4 3.0
PUFA (g) 13.2 6.1
% en PUFA 6.3 2.2
MUFA:SFA1 0.9 0.2
PUFA:SFA 0.5 0.2
Cholesterol (mg)1 252 117
Trans fats (g)2 1.1 1.0
% en trans fats3 0.5 0.4
Alcohol (g)1 11.9 14.6
% en alcohol1 4.1 5.0
Sodium (mg/10 MJ) 3745.2 794.0
Vitamin C (mg/10 MJ)1 209.4 434.8
Vitamin E (mg/10 MJ )1 10.6 4.4
Vitamin D (μg/10 MJ)1 4.2 5.8
Carotene (μg/10 MJ)3 3484.2 2357.3
Folate (μg/10 MJ)3 367.3 189.3
Potassium (mg/10 MJ) 4022.1 856.6
Magnesium (mg/10 MJ)1 371.5 70.0
Zinc (mg/10 MJ)3 12.3 2.95
Micronutrient Adequacy Score (range 0–8) 1.6 1.4
T2DM type 2 diabetes mellitus, SD standard deviation, N subject numbers, % en per
SFA saturated fatty acids, MUFA mono-unsaturated fatty acids, PUFA poly-unsaturate
1 Log transformation; 2 Square root transformation; 3 Non-parametric 2-tailed t-test
between T2DM group and control group.
Subject numbers may vary due to missing data.
Statistically significant (P < 0.05).groups. No statistically significant differences were found
in mean macronutrient intakes between the two groups
and when micronutrient intake was assessed, it was
found that those with T2DM consumed significantly less
Vitamin D (4.2 ± 5.8 μg/10 MJ) than the control group
(8.1 ± 6.7 μg/10 MJ) (P < 0.001). In addition, the T2DMgroups
Controls P value
N Mean SD N
65 7.8 2.3 46 0.519
65 83.4 26.6 46 0.632
65 18.4 5.0 46 0.905
65 199.8 71.3 46 0.128
65 40.0 7.8 46 0.183
65 78.4 33.2 46 0.737
65 15.8 5.4 46 0.326
65 32.6 22.4 46 0.741
65 18.7 6.0 46 0.861
65 73.2 26.1 46 0.525
65 34.9 6.0 46 0.824
65 25.9 9.8 46 0.498
65 12.3 2.8 46 0.622
65 24.1 9.9 45 0.592
65 11.4 2.8 45 0.824
65 11.6 5.8 45 0.084
65 5.6 2.0 45 0.066
65 0.9 0.2 45 0.849
65 0.4 0.2 45 0.090
65 283 153 46 0.925
65 1.1 1.0 45 0.912
65 0.5 0.4 45 0.796
65 17.9 18.4 46 0.912
65 6.3 6.8 46 0.964
65 3558.8 1133.7 46 0.137
65 139.9 75.5 46 0.184
65 11.7 5.3 46 0.264
65 8.1 6.7 46 0.000
65 5066.4 6314.6 45 0.253
65 501.6 994.3 46 0.756
65 4185.1 851.1 46 0.324
65 398.4 100.6 46 0.133
65 13.8 5.6 46 0.148
65 2.3 1.4 46 0.009
centage total energy, CHO carbohydrate, NMES non-milk extrinsic sugars,
d fatty acids.
analysis. All other p-values obtained by independent 2-tailed t-test analyses
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nutrient Adequacy was assessed (T2DM; 1.6 ± 1.4, con-
trol; 2.3 ± 1.4, P = 0.009).
Food group analyses
Due to the nature of recruitment and analysis per-
formed, food group data was not available for all partici-
pants and has resulted in some missing values. In total,
31 subjects had missing values for some parameters.
Mean daily intake of 19 food groups, measured by
weight, is presented in Table 3. The top 5 most com-
monly consumed food groups of the T2DM group were,
in descending order of intake, alcoholic drinks, fruit,
meat and meat products, vegetables, and bread. For the
control group, the top 5 foods consumed were alcoholic
drinks, vegetables, fruit, potatoes and meat and meat
products. Participants with T2DM were found to con-
sume significantly more bread (P = 0.019), fats and oilsTable 3 Mean (SD) daily food group intake of T2DM and cont
T2DM
Mean SD N
Food group
Bread (g)3 112.9 69.9 4
Breakfast cereals (g)2 42.1 43.8 4
Potatoes (g)1 96.8 59.8 4
Rice/pasta/other (g)3 50.3 56.0 4
Wholegrains (g)2 42.1 41.7 3
Legumes (g)2 8.2 20.9 3
Vegetables (g) 129.3 58.7 4
Fruit (g) 162.0 95.3 4
Nuts (g)2 5.9 10.7 3
Seeds (g)2 2.1 6.1 3
Meat & meat products (g)2 135.8 67.8 4
Fish (g)2 19.6 31.5 4
Red meat (g)3 62.3 48.7 3
White meat (g)3 41.8 34.0 3
Processed meats (g)3 35.2 29.0 3
Milk / cream (g)2 198.54 134.9 4
Cheese (g)2 13.74 17.31 4
Yogurts (g)2 40.76 50.51 4
Ice-cream (g)2 4.87 11.82 4
Biscuits & cakes (g)2 47.4 50.4 4
Sugar & confectionary (g)2 19.5 32.9 4
Fats & oils (g)3 15.6 10.7 4
Alcoholic drinks (g)2 251.2 425.0 4
T2DM type 2 diabetes mellitus, SD standard deviation, N subject numbers.
1Square root transformation; 2 Log transformation; 3 Non-parametric t-test analysis.
T2DM group and control group.
Subject numbers may vary due to missing data.
Statistically significant (P < 0.05).(P = 0.021) and processed meats (P = 0.026) and signifi-
cantly less vegetables (P = 0.046) than the control group.
Dietary quality analyses
Table 4 presents the mean dietary quality scores for the
T2DM group and control group as per the Mediterranean
Diet Score, the Alternate Mediterranean Diet Score, the
Healthy Diet Indicator and the Alternate Healthy Eating
Index. The T2DM group were found to have a signifi-
cantly lower (P < 0.001) Mediterranean Diet Score when
compared to the control group (T2DM; 3.4 ± 1.3, control;
4.8 ± 1.8). A similar result was also found when the Alter-
nate Mediterranean Diet Score was applied (T2DM; 3.3 ±
1.5, control; 4.2 ± 1.8, P = 0.022). The T2DM group were
also found to have a significantly lower (P = 0.001) Healthy
Diet Indicator score than the control group (T2DM; 2.6 ±
2.3, control; 3.3 ± 1.1), indicating poorer quality of dietary
intake in the T2DM group. No significant difference wasrol groups
Controls P value
Mean SD N
7 74.2 48.6 45 0.003
7 53.8 52.7 45 0.327
7 108.6 80.5 45 0.283
7 76.5 81.2 45 0.141
9 34.6 39.0 41 0.161
9 9.3 16.2 41 0.280
7 155.8 94.3 45 0.046
7 151.4 118.9 45 0.088
9 6.5 19.7 41 0.089
9 9.0 21.2 41 0.240
7 108.2 78.4 45 0.748
7 57.3 60.0 45 0.933
9 51.1 42.3 41 0.317
9 41.2 62.3 41 0.136
9 24.1 34.0 41 0.026
9 106.98 97.62 45 0.000
9 17.93 23.08 45 0.913
1 35.36 45.51 41 0.241
1 3.10 8.44 41 0.841
7 43.6 44.4 45 0.725
7 31.0 61.6 45 0.181
7 11.8 10.4 45 0.048
7 298.4 392.0 45 0.063
All other p-values obtained by independent 2-tailed t-test analyses between
Table 4 Mean (SD) dietary quality index scores for T2DM and control groups
T2DM Controls P value
Mean SD N Mean SD N
Dietary quality index
Mediterranean diet score1 3.4 1.3 39 4.8 1.8 41 <0.001
Alternate mediterranean diet score1 3.3 1.5 39 4.2 1.8 41 0.022
Healthy diet indicator1 2.6 2.3 39 3.3 1.1 41 0.001
Alternate healthy eating index 40.2 10.8 39 41.9 11.7 41 0.513
T2DM type 2 diabetes mellitus, SD standard deviation, N subject numbers.
1 Non-parametric 2-sided t-test analysis. All other p-values obtained by independent 2-sided t-test analyses between T2DM group and control group.
Subject numbers may vary due to missing data.
Statistically significant (P < 0.05).
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the T2DM and control groups.Table 5 Significant partial correlations of dietary intake,
anthropometry and biochemical parameters for total
sample population
Variable 1 Variable 2 r value P value
Weight (kg) FPG +0.37 <0.001
HbA1c +0.27 0.009
Insulin1 +0.34 0.032
TAG +0.45 <0.001
BMI FPG +0.43 <0.001
HbA1c +0.27 0.006
Insulin1 +0.48 <0.001
TAG +0.43 <0.001
WC (cm) Insulin1 +0.53 <0.001
TAG +0.35 0.014Correlation analyses
Spearman rho correlation analyses found that a number
of chosen DQIs were significantly correlated to each
other. The Mediterranean Diet Score had a significant
positive correlation to the Alternate Mediterranean Diet
Score (r = +0.7, P < 0.001), the Alternate Healthy Eating
Index (r = +0.4, P < 0.001) and the Healthy Diet Indicator
(r = +0.3, P = 0.001). The Alternate Mediterranean Diet
Score was also found to be positively correlated to the
Alternate Healthy Eating Index (r = +0.6, P < 0.001) and
the Healthy Diet Indicator (r = +0.3, P = 0.007). No other
significant correlations were observed.
Partial correlation analyses were also carried out be-
tween nutrient, food group, anthropometrical and bio-
chemical data. Further significant associations observed
are presented in Table 5. Partial correlation analyses
were also carried out between nutrient, food group,
anthropometrical and biochemical data and further sig-
nificant associations observed are presented in Table 5.
Table 6 outlines the scoring system for each dietary
quality index and the relevant health outcomes which
were found to be associated with each index in the pub-
lished literature.Fibre −0.28 0.018
Mediterranean diet score BMI −0.27 0.042
FPG −0.36 0.001
HbA1c −0.26 0.024
Alternate mediterranean diet score FPG −0.27 0.021
Healthy diet indicator FPG −0.25 0.027
FPG fasting plasma glucose, HbA1c glycosylated haemoglobin,
TAG triacylglycerides, BMI body mass index, WC waist circumference.
1 T2DM group only.
Partial correlation coefficients (r) controlled for covariates; Participants taking
statin medications excluded from lipid analysis; Participants taking oral
hypoglycaemic agents excluded from glycaemic profile analysis; All analyses
controlled for age; Dietary intake analysis control for energy intake. No
significant partial correlations observed in relation to alternate healthy
eating index.
Statistically significant (P < 0.05).Discussion
This study found that the overall quality of dietary in-
take consumed by a sample of individuals with T2DM
was less than that of a healthy control population when
measured using the Mediterranean Diet Score, the Al-
ternate Mediterranean Diet Score and the Healthy Diet
Indicator. Conversely, when individual macronutrient in-
takes were assessed, no differences were observed be-
tween those with and without T2DM. Given that the
design of the current study is of a cross-sectional case–
control nature, a cause and effect relationship bet-
ween dietary quality and incidence of T2DM cannot
be determined.Lifestyle is considered a cornerstone both in the treat-
ment and management of T2DM [30,31]. The results of
the current study show that individuals with T2DM con-
sumed a diet significantly less like the Mediterranean
dietary pattern compared to a non-T2DM population, as
assessed by the Mediterranean Diet Score and Alternate
Mediterranean Diet Score. In addition, there was a sig-
nificant inverse association between the Mediterranean
diet score and BMI as well as fasting plasma glucose
and fasting plasma insulin, recognised as parameters
Table 6 Summary of dietary quality indices
Dietary quality index Author(s) Score Measure Associations
Mediterranean diet
score
Trichopoulou et al., 1995 Range: 0–9 Adherence to a traditional
Mediterranean dietary pattern
● Inversely associated with overall
mortality [9]
● Significant reduction in total
mortality [11]
● Inversely associated with cancer
disease risk [22-24]
Alternate mediterranean
diet score
Fung et al., 2005 Range: 0–9 Adherence to a Mediterranean
dietary pattern. Adapted score
to give greater focus on within
food group quality
● Inverse association with inflammatory
biomarkers [12]
● Lower incident of mortality from
coronary heart disease and stroke [25]
● Significant inverse association with
BMI and obesity [26]
Alternate healthy
eating index
McCullough et al., 2002 Range: 2.5–87.5 Adherence to USA dietary guidelines
and the USA My Food Pyramid.
Adapted score to give greater
focus on within food group quality
● Significant reduction in overall chronic
disease risk, with greater strength in
prediction of chronic disease risk when
compared to the original Healthy
Eating Index [27]
● Inverse association with inflammatory
biomarkers [12]
● Reduction in overall disease risk and
risk of premature mortality from
coronary vascular disease [28]
Healthy diet indicator Huijbregts et al., 1997 Range: 0–9 Adherence to WHO 1990 dietary
recommendations for the
prevention of chronic disease
● Significantly inverse association with
20 year all-cause mortality in a
multi-cultural population [13]
● Significantly correlated with nutritional
adequacy (MAR) [29]
BMI Body mass index, USA United States of America, MAR mean adequacy ratio.
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vational analyses and intervention studies suggest that
adherence to a specific dietary pattern that promotes
metabolic health may be more beneficial than adherence
to individual nutrient based recommendations [32]. The
Mediterranean dietary pattern is characterised by high in-
takes of fibre, lean meats and fruit and vegetables [9,11].
Concern was initially raised as to the relatively high fat
content of the Mediterranean diet, which can have up to
40% total energy derived from fat, and the effects that this
could mediate on body mass and metabolic health. How-
ever, several epidemiological studies have shown that the
Mediterranean dietary pattern is inversely associated with
weight gain, BMI and T2DM risk [26,33,34]. Furthermore,
evidence suggests that the Mediterranean dietary pattern
has beneficial effects on lipid and glycaemic profiles
[12,35-37].
The current study showed that those individuals with
T2DM had a lower score than the control group when
dietary pattern was assessed using the Healthy Diet Indi-
cator (HDI). Whereas several epidemiological studies
and systematic reviews have examined the relationship
between the Mediterranean dietary pattern and T2DM
risk [7,32,33], to the best of our knowledge the current
study is the first to examine dietary intake using theHDI in a sample of individuals with T2DM. The HDI is
based on the WHO guidelines for diet and nutrition in
the prevention of chronic disease and whilst the current
study design prevents cause and effect inferences to be
drawn, it is interesting that the T2DM cohort scored sig-
nificantly lower than the control participant using this
dietary pattern score. Conversely, no significant differ-
ence was found in dietary quality scores between the
T2DM and control groups when measured using the Al-
ternate Healthy Eating Index. While speculative, this re-
sult may be due to the fact that while the other DQIs
use a predefined cut off point in the allocation of scores,
the Alternate Healthy Eating Index allocates scores for a
wider range of intakes.
Individuals with T2DM also scored significantly lower
when micronutrient intake was assessed using the Mi-
cronutrient Adequacy Score, a result that highlights that
although micronutrient adequacy was suboptimal in
both groups, individuals with T2DM consumed a more
nutrient dilute diet than their insulin sensitive counter-
parts. When the intake of nine individual micronutrients
was assessed, individuals with T2DM consumed signifi-
cantly less Vitamin D than the control group. Emerging
evidence suggests that supplementing vitamin D in indi-
viduals with impaired glucose tolerance improves insulin
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been inconsistent [38,39].
Much research has been carried out on the effects of
different dietary patterns on body composition, meta-
bolic health and disease risk. A Western dietary pattern
with characteristic consumption of high levels of satu-
rated fatty acids, red and processed meats, confectionery
and refined grains has been associated with increased
T2DM risk and deterioration of metabolic health, inde-
pendent of weight status [2,40,41]. In the current study,
food group analyses found that the T2DM group had a
high consumption from the fruit and vegetable food
groups yet failed to reach the recommended intake of
400 g of fruit and vegetables per day [31]. The third
highest food group consumption of the T2DM group
came from meat and meat products. Total cereal grain
consumption was notably higher than consumption of
wholegrain cereals alone for the T2DM group. This sug-
gests a greater consumption of refined cereal grains
within this group. The T2DM group also consumed sig-
nificantly more fats and oils, processed meats and bread
than the control group. These findings represent features
of a Western dietary pattern. Conversely, consumption
of a prudent dietary pattern, which includes intake of
fruit and vegetables, lean meats and wholegrains, charac-
teristic components of a Mediterranean dietary pattern,
has been found in other studies to be protective to meta-
bolic health [2,42].
Evidence suggests that even short term hyperglycaemia
results in increased vascular intracellular adhesion mole-
cules in individuals with T2DM, a risk factor for athe-
rosclerosis [43,44]. This supports a need for greater
adherence to a dietary pattern that promotes increased
amounts of fibre containing foods in order to regulate
the hyperglycaemic response [45,46]. Fibre independ-
ently affects metabolic health. The current analysis
found that total fibre intake had a significant negative
association with waist circumference. Similar results
have also been found in previous analyses [47,48]. Given
the substantial evidence to support WC as an indicator
of cardiometabolic disease risk [49], the current results
suggest that fibre may play a role in the attenuation of
obesity induced metabolic dysregulation.
Excess adiposity is associated with increased morbidity
and mortality [50]. Thirty-nine percent of the total po-
pulation in this study were overweight. This is consistent
with recent findings which concluded that 37% of a rep-
resentative sample of the Irish population were over-
weight [21]. At group level, the control group have a
similar mean BMI, 27.6, when compared to a representa-
tive sample of the Irish population at 27.5. However, the
T2DM group was found to have a BMI of 32.5 which is
significantly greater than the control population. Given
the known association between the Mediterranean DietScore and BMI and weight status [26,34], it must be
noted that such differences in BMI between the two
groups may have potentially contributed to the T2DM
group having a significantly lower dietary quality score
than the control group.
The strengths of the current study were that at group
level there was no significant difference in age or activity
level between the participants with T2DM and the con-
trol group, and that control participants were a repre-
sentative sample of the national population in terms of
BMI and habitual nutrient intake by comparison with
the recently published national data [21]. There are how-
ever, limitations associated with the current study. The
first is the fact that validation of reported dietary energy
intake data using the Goldberg method [51] revealed sig-
nificant misreporting in this sample of Irish adults.
Based on estimates of energy expenditure, seventy-four
of the 111 subjects (66.6%) in this study were found to
under-report their dietary intake, which is likely to ex-
plain the relatively low mean energy intake observed.
However, the mean level of under-reporting was similar
in both groups, suggesting that while mean nutrient in-
takes may be under-estimated in this cohort, any differ-
ences or lack thereof, detected between the two groups,
remain. Studies suggest that the mis-reporting of dietary
energy is a serious problem in any study of dietary
intake [52]. Moreover, obesity affects both the quan-
tity and quality of reported dietary energy intake data
[53,54]. As 86% of the participants of this current study
were overweight or obese (98% T2DM and 70% control)
this will without doubt have contributed to the high
level of energy under-reporting observed. Furthermore, a
high level of under-reporting of energy intake has also
been noted in individuals with T2DM [55,56]. The se-
cond limitation is that although the two groups were
similar in terms of age and activity level, a significant
difference was found in BMI between the two groups.
Thirdly, it must also be noted that some participants in
the T2DM group may have previously received dietary
advice from a healthcare professional which may have
affected habitual dietary intake in this group. The fourth
limitation is that there was no gender balance between
the adults with T2DM and the controls. There were 39
male and 26 female participants with T2DM yet there
were only 16 males and 30 females in the control group.
Another limitation is that the cases and controls were
not matched socio-economically. Whilst they were all
recruited from the same catchment area in Dublin,
Ireland, no objective measure of socio-economic status
was used. A final limitation is that this study also has a
cross-sectional design with a relatively small sample size
allowing only observation of any associations between
nutrient intake, dietary quality and metabolic health in a
sample of individuals with T2DM. Further confirmation
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controlled trials.
Conclusions
In conclusion, the current cross-sectional study found
that when compared to a control population, partici-
pants with T2DM consumed a diet of lower overall qua-
lity, despite the fact that no differences in individual
macronutrient intake were detected. When dietary in-
take was assessed using a series of validated dietary qual-
ity indices, the T2DM group consumed a dietary pattern
that is more representative of a typical westernised diet-
ary pattern than the control population. These findings
suggest that using dietary patterns to model dietary re-
commendations may be more beneficial than nutrient
based approaches.
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